At AAN 2024, Mickey Matsumoto, Ph.D., CSO of Arialys, will give an oral presentation entitled, "Peripherally Administered Therapeutic One-armed Antibody Reversed Behavioral Abnormalities in a Marmoset Model of Anti-NMDAR Encephalitis."

‍

View the abstract and more details here.

‍